日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An introduction to BASIC Guide: human biomonitoring and surveillance of chemical exposure in occupational settings

BASIC指南简介:职业环境中化学物质暴露的人体生物监测和监控

Zare Jeddi, Maryam; Jones, Kate; Leese, Elizabeth; Fustinoni, Silvia; Galea, Karen S; Santonen, Tiina; Porras, Simo P; Hopf, Nancy B; Göen, Thomas; Bader, Michael; Tranfo, Giovanna; Tristram, Adrian; Iavicoli, Ivo; Leso, Veruscka; Koch, Holger M; Pasanen-Kase, Robert; Boogaard, Peter J; Persoons, Renaud; Esteban-López, Marta; Verpaele, Steven; Kasiotis, Konstantinos M; Machera, Kyriaki; Carrieri, Mariella; Palmen, Nicole; Duca, Radu-Corneliu; van Nieuwenhuyse, An; Gonzales, Melissa; Haynes, Erin N; Viegas, Susana; Bessems, Jos; Makris, Konstantinos C; Connolly, Alison; Teixeira, João Paulo; Chung, Ming Kei; Parsons, Patrick J; Kumar, Eva; Lin, Elizabeth Ziying; Kil, Jihyon; Kwon, Jung-Hwan; Tavares, Ana Maria; Vekic, Ana Maria; Souza, Gustavo; Scheepers, Paul T J

NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis

NRF2 促进非小细胞肺癌的生长,且该作用独立于 CBP/p300 增强的谷胱甘肽合成。

Ryan J Conrad #,James A Mondo #,Mike Lingjue Wang,Peter S Liu,Zijuan Lai,Feroza K Choudhury,Qingling Li,Weng Ruh Wong,James Lee,Frances Shanahan,Eva Lin,Scott Martin,Joachim Rudolph,John G Moffat,Dewakar Sangaraju,Wendy Sandoval,Timothy Sterne-Weiler,Scott A Foster

COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway

BRAFV600E黑色素瘤中COP1缺陷导致对MAPK通路抑制剂的耐药性

Ada Ndoja,Christopher M Rose,Eva Lin,Rohit Reja,Jelena Petrovic,Sarah Kummerfeld,Andrew Blair,Helen Rizos,Zora Modrusan,Scott Martin,Donald S Kirkpatrick,Amy Heidersbach,Tao Sun,Benjamin Haley,Ozge Karayel,Kim Newton,Vishva M Dixit

The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity

外切酶 TREX1 构成先天免疫检查点,限制 cGAS/STING 介导的抗肿瘤免疫

Junghyun Lim #, Ryan Rodriguez #, Katherine Williams, John Silva, Alan G Gutierrez, Paul Tyler, Faezzah Baharom, Tao Sun, Eva Lin, Scott Martin, Brandon D Kayser, Robert J Johnston, Ira Mellman, Lélia Delamarre, Nathaniel R West, Sören Müller, Yan Qu #, Klaus Heger #

Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study)

脉冲场消融与高功率短时射频消融治疗阵发性房颤的肺静脉隔离:疗效、安全性和长期随访(PRIORI 研究)

Reinsch, Nico; Füting, Anna; Hartl, Stefan; Höwel, Dennis; Rausch, Eva; Lin, Yali; Kasparian, Karampet; Neven, Kars

Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in Melanoma

药物反应的计算模型确定了黑色素瘤中 panRAF 和 MEK 抑制剂给药的突变特异性限制

Andrew Goetz, Frances Shanahan, Logan Brooks, Eva Lin, Rana Mroue, Darlene Dela Cruz, Thomas Hunsaker, Bartosz Czech, Purushottam Dixit, Udi Segal, Scott Martin, Scott A Foster, Luca Gerosa

Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma

药物反应的计算模型确定了黑色素瘤中 panRAF 和 MEK 抑制剂剂量突变特异性限制

Andrew Goetz, Frances Shanahan, Logan Brooks, Eva Lin, Rana Mroue, Darlene Dela Cruz, Thomas Hunsaker, Bartosz Czech, Purushottam Dixit, Udi Segal, Scott Martin, Scott A Foster, Luca Gerosa

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

变构泛 TEAD 抑制剂阻断致癌 YAP/TAZ 信号传导并克服 KRAS G12C 抑制剂耐药性

Thijs J Hagenbeek #, Jason R Zbieg #, Marc Hafner #, Rana Mroue, Jennifer A Lacap, Nicole M Sodir, Cameron L Noland, Shervin Afghani, Ayush Kishore, Kamakoti P Bhat, Xiaosai Yao, Stephen Schmidt, Saundra Clausen, Micah Steffek, Wendy Lee, Paul Beroza, Scott Martin, Eva Lin, Rina Fong, Paola Di Lello

Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors

变构型 AKT 抑制剂与 ATP 竞争型 AKT 抑制剂存在不同的耐药机制

Kristin M Zimmerman Savill, Brian B Lee #, Jason Oeh #, Jie Lin #, Eva Lin, Wei-Jen Chung, Amy Young, Wennie Chen, Monika Miś, Kathryn Mesh, Jeffrey Eastham, Florian Gnad, Zhaoshi Jiang, Eric W Stawiski, Benjamin Haley, Anneleen Daemen, Xiaojing Wang, Hartmut Koeppen, Zora Modrusan, Scott E Martin, 

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

PROTAC 介导的 SMARCA2 选择性降解对 SMARCA4 突变癌症有效

Jennifer Cantley, Xiaofen Ye, Emma Rousseau, Tom Januario, Brian D Hamman, Christopher M Rose, Tommy K Cheung, Trent Hinkle, Leofal Soto, Connor Quinn, Alicia Harbin, Elizabeth Bortolon, Xin Chen, Roy Haskell, Eva Lin, Shang-Fan Yu, Geoff Del Rosario, Emily Chan, Debra Dunlap, Hartmut Koeppen, Scott